20 participants
A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-05-07
- Start Date:
- 2015-03-31
- Completion:
- 2016-09-30
Conditions
- Pancreatic Cancer
Interventions
- DRUG